News
GoodRx and Novo Nordisk are partnering to lower costs for Ozempic and Wegovy. Patients can use GoodRx to access ...
As Novo Nordisk transitions from the leadership of longtime CEO Lars Fruergaard Jørgensen to newly appointed chief Maziar ...
The move is likely part of the company’s goal to reduce costs as it faces increased competition in the GLP-1 space.
Doustdar, a longtime company insider, took up the chief executive role on Aug. 7, a week after Novo Nordisk cut its outlook for the second time this year blaming competition from copycat versions of ...
It faces more than 1,800 lawsuits consolidated in federal court in Pennsylvania and new claims emerging weekly, according to ...
About Robbins LLP : A recognized leader in shareholder rights litigation, the attorneys and staff of Robbins LL have been dedicated to helping shareholders recover losses, improve corporate governance ...
The side effect is rare, according to a new study, but is also the subject of multiple lawsuits, including two filed by Long ...
Novo Nordisk, the Denmark-based pharmaceutical company that makes Ozempic and Wegovy, looks like it's being toppled off its ...
This is an audio transcript of the FT News Briefing podcast episode: ‘What to expect from Jay Powell’s Jackson Hole speech’ Sonja Hutson Good morning from the Financial Times. Today is Wednesday, ...
HUNDREDS of thousands more Brits could be offered weight loss jabs on the NHS in the biggest shake up of diabetes care in a decade – as the health service prepares to ease rules around ...
Novo Nordisk announced Monday that US patients can now get a month’s supply of Ozempic, the blockbuster diabetes drug, for ...
9h
StockStory.org on MSNNoodles, GoodRx, Micron, Custom Truck One Source, and CarMax Shares Are Falling, What You Need To Know
What Happened? A number of stocks fell in the afternoon session after the major indices continued to pull back, with technology stocks accounting for most of the market's largest decliners. A key ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results